SMS femoral stem clinical trials

The Medacta International SMS Post-Marketing Surveillance Study

This study looks at a new hip replacement part called the SMS femoral stem. It follows people aged 18-75 in the UK who have a total hip replacement due to severe hip pain from conditions like arthritis, to see how well the new part works over time.